Psyence Biomedical Management
Management criteria checks 1/4
Psyence Biomedical's CEO is Jody Aufrichtig, appointed in Oct 2025, has a tenure of less than a year. total yearly compensation is $216.67K, comprised of 92.3% salary and 7.7% bonuses, including company stock and options. directly owns 0.059% of the company’s shares, worth $880.49. The average tenure of the management team and the board of directors is 0.2 years and 1.4 years respectively.
Key information
Jody Aufrichtig
Chief executive officer
US$216.7k
Total compensation
| CEO salary percentage | 92.31% |
| CEO tenure | less than a year |
| CEO ownership | 0.06% |
| Management average tenure | less than a year |
| Board average tenure | 1.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | -US$4m |
| Jun 30 2025 | n/a | n/a | -US$1m |
| Mar 31 2025 | US$217k | US$200k | US$1m |
| Dec 31 2024 | n/a | n/a | -US$23m |
| Sep 30 2024 | n/a | n/a | -US$47m |
| Jun 30 2024 | n/a | n/a | -US$49m |
| Mar 31 2024 | US$185k | US$110k | -US$51m |
| Dec 31 2023 | n/a | n/a | -US$28m |
| Sep 30 2023 | n/a | n/a | -US$4m |
| Jun 30 2023 | n/a | n/a | -US$4m |
| Mar 31 2023 | US$124k | US$85k | -US$3m |
Compensation vs Market: Jody's total compensation ($USD216.67K) is below average for companies of similar size in the US market ($USD596.08K).
Compensation vs Earnings: Jody's compensation has increased whilst the company is unprofitable.
CEO
Jody Aufrichtig (51 yo)
Mr. Jody Aufrichtig is Chief Executive Officer of Psyence Biomedical Ltd. from October 2025 and as its Executive Chairman since January 25, 2024. Mr. Aufrichtig is a Co-Founder of Psyence Group Inc. and se...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | less than a year | US$216.67k | 0.059% $ 880.5 | |
| CFO & Director | 1.9yrs | US$195.00k | 0.030% $ 452.2 | |
| Global Head of Clinical Development | less than a year | US$390.00k | 0.092% $ 1.4k | |
| General Counsel | no data | no data | no data |
Experienced Management: PBM's management team is not considered experienced ( 0.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 1.9yrs | US$216.67k | 0.059% $ 880.5 | |
| CFO & Director | less than a year | US$195.00k | 0.030% $ 452.2 | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board & Independent Director | 1.9yrs | no data | 0.0062% $ 92.4 | |
| Independent Director | 1.9yrs | no data | 0.017% $ 258.0 | |
| Independent Director | 1.9yrs | no data | 0.021% $ 316.1 | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Chairman of Scientific Advisory Board | less than a year | no data | no data |
Experienced Board: PBM's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/12/31 14:10 |
| End of Day Share Price | 2025/12/31 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Psyence Biomedical Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.